Search
![](/contentassets/a94b5755a9754ad287103240f25e8189/intro-session.jpg)
News & Events
Expert researchers converge on Broome to tackle health challenges in Northern AustraliaOver 100 researchers and health professionals from around Australia have united in Broome this week to address the major health battles facing people living in the tropical north of the country.
Research
A diagnostic test for acute rheumatic fever (pilot study)Jonathan Tim Carapetis AM Barnett AM MBBS FRACP FAFPHM PhD FAHMS PhD Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH Head,
Research
Burden of rheumatic heart disease (RHD) and impact of prevention strategies: comprehensive evidence to drive the RHD EndgameJonathan Judy Rosemary Carapetis AM Katzenellenbogen Wyber AM MBBS FRACP FAFPHM PhD FAHMS BSc (Occ Ther) BSc Hons (Epidemiol) MSc PhD MBChB MPH
Research
Controlled Human Infection for Penicillin Against Streptococcus pyogenes – a double blinded randomised trail (The CHIPS trial)Jonathan Carapetis AM AM MBBS FRACP FAFPHM PhD FAHMS Executive Director; Co-Head, Strep A Translation; Co-Founder of REACH 08 6319 1000 contact@
Research
Improved diagnosis, treatment and prevention of recurrent tonsillitisAnthony Janessa Ruth Tim Kicic Pickering Thornton Barnett BSc (Hons) PhD BSc PhD PhD PhD Rothwell Family Fellow; Head, Airway Epithelial Research
Research
Reach: to stop rheumatic heart diseaseRosemary Sophie Jonathan Wyber La Vincente Carapetis AM MBChB MPH FRACGP PhD BPsych (Hons) MAppEpi PhD AM MBBS FRACP FAFPHM PhD FAHMS Senior Research
Research
The END RHD CRE: Developing an end game for rheumatic heart disease in AustraliaJonathan Glenn Katharine Rosemary Tom Carapetis AM Pearson Noonan Wyber Snelling AM MBBS FRACP FAFPHM PhD FAHMS BA (Education) PhD Candidate MBBS (
Research
Changes in the clinical and epidemiological features of group A streptococcal bacteraemia in Australia's northern territoryWe aimed to measure the incidence and severity of invasive Group A Strep disease in the NT since 1996.
Research
Utility of auscultatory screening for detecting rheumatic heart disease in high-risk children in Australia's Northern TerritorySensitivity and positive predictive value of cardiac auscultation compared with echocardiography is poor, regardless of the expertise of the auscultator.
Research
Secondary Antibiotic Prophylaxis for Latent Rheumatic Heart DiseaseRheumatic heart disease affects more than 40.5 million people worldwide and results in 306,000 deaths annually. Echocardiographic screening detects rheumatic heart disease at an early, latent stage. Whether secondary antibiotic prophylaxis is effective in preventing progression of latent rheumatic heart disease is unknown.